Hefei Lifeon Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004BD9
CNY
26.83
0.52 (1.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,496.06
1,882.45
2,563.38
2,256.99
1,881.90
1,640.60
1,416.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,496.06
1,882.45
2,563.38
2,256.99
1,881.90
1,640.60
1,416.08
Raw Material Cost
499.65
938.75
1,631.47
1,378.28
1,268.08
1,139.86
1,005.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
156.87
143.69
122.27
105.82
81.65
78.64
65.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.00
1.40
1.25
1.57
0.52
1.47
2.87
Selling and Distribution Expenses
748.77
651.01
664.25
641.58
428.61
357.94
290.37
Other Expenses
-7.17
-6.52
-5.46
-4.51
-4.17
-4.56
-4.73
Total Expenditure (Excl Depreciation)
1,335.56
1,669.67
2,364.63
2,082.16
1,737.20
1,532.29
1,317.27
Operating Profit (PBDIT) excl Other Income
160.5
212.8
198.79999999999998
174.8
144.70000000000002
108.3
98.80000000000001
Other Income
18.82
50.31
50.29
27.96
13.79
16.40
14.77
Operating Profit (PBDIT)
256.56
304.60
283.47
238.46
173.62
138.41
125.42
Interest
2.00
1.40
1.25
1.57
0.52
1.47
2.87
Exceptional Items
-4.07
0.50
-0.18
-0.27
0.00
-0.15
0.00
Gross Profit (PBDT)
996.40
943.70
931.91
878.71
613.82
500.73
410.64
Depreciation
86.49
47.34
38.21
38.49
16.16
15.17
14.13
Profit Before Tax
163.99
256.36
243.83
198.14
156.94
121.62
108.43
Tax
19.34
23.53
30.57
22.61
21.82
16.48
16.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
160.60
226.67
209.25
172.23
135.12
105.14
91.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
160.60
226.67
209.25
172.23
135.12
105.14
91.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.12
7.21
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
152.48
233.88
209.25
172.23
135.12
105.14
91.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,737.89
1,685.53
1,479.86
1,303.91
1,173.99
590.00
505.70
Earnings per share (EPS)
0.84
1.19
1.11
0.92
0.72
0.56
0.49
Diluted Earnings per share
0.84
1.19
1.11
0.92
0.72
0.56
0.49
Operating Profit Margin (Excl OI)
10.11%
10.99%
7.61%
7.62%
7.63%
6.51%
6.82%
Gross Profit Margin
16.74%
16.13%
11.0%
10.48%
9.2%
8.34%
8.65%
PAT Margin
10.73%
12.04%
8.16%
7.63%
7.18%
6.41%
6.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -20.53% vs -26.56% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -34.80% vs 11.81% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -6.53% vs 9.05% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 42.86% vs 16.67% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Hefei Lifeon Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,496.06
0
1,496.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,496.06
0
1,496.06
Raw Material Cost
499.65
0
499.65
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
156.87
0
156.87
Power Cost
0
0
0.00
Manufacturing Expenses
2.00
0
2.00
Selling and Distribution Expenses
748.77
0
748.77
Other Expenses
-7.17
0.00
-7.17
Total Expenditure (Excl Depreciation)
1,335.56
0
1,335.56
Operating Profit (PBDIT) excl Other Income
160.50
0.00
160.50
Other Income
18.82
0
18.82
Operating Profit (PBDIT)
256.56
0
256.56
Interest
2.00
0
2.00
Exceptional Items
-4.07
0
-4.07
Gross Profit (PBDT)
996.40
0
996.40
Depreciation
86.49
0
86.49
Profit Before Tax
163.99
0
163.99
Tax
19.34
0
19.34
Provisions and contingencies
0
0
0.00
Profit After Tax
160.60
0
160.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
160.60
0
160.60
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.12
0
-8.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
152.48
0
152.48
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,737.89
0
1,737.89
Earnings per share (EPS)
0.84
0
0.84
Diluted Earnings per share
0.84
0
0.84
Operating Profit Margin (Excl OI)
10.11%
0%
0.00
10.11%
Gross Profit Margin
16.74%
0%
0.00
16.74%
PAT Margin
10.73%
0%
0.00
10.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 149.61 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -20.53% vs -26.56% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 15.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -34.80% vs 11.81% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -6.53% vs 9.05% in Dec 2023

Annual - Interest
Interest 0.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 42.86% vs 16.67% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.11%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023